Polycystic Ovary Syndrome (PCOS): Symptoms, Causes, and Treatment
Authors:
Top Cited Papers
Open Access
- 21 May 2024
- journal article
- review article
- Published by IMR Press in Clinical and Experimental Obstetrics & Gynecology
- Vol. 51 (5) , 126
Abstract
Objective: The review aims to provide an overview of the pathogenesis, clinical manifestations, and treatment methods of polycystic ovary syndrome (PCOS). Mechanism: The etiology of PCOS is multifaceted, intricately intertwined with genetic determinants, dysregulation of the hypothalamic-pituitary-ovarian axis, adrenal androgen excess, ethnic predilections, insulin resistance, persistent inflammatory cascades, lifestyle variables, non-coding RNA (ncRNA), and oxidative stress manifestations. Findings in Brief: Advances in PCOS research have led to updated diagnostic criteria that focus on irregular menstruation, along with the introduction of new treatments such as glucagon-like peptide-1 (GLP-1) agonists and sodium-glucose cotransporter 2 (SGLT2) inhibitors. Additionally, innovative reproductive technologies like in vitro fertilization (IVF) with intracytoplasmic sperm injection (ICSI) are showing promise in improving fertility outcomes for PCOS patients. Genetic and epigenetic studies are uncovering potential for personalized therapeutic interventions. Individuals with PCOS face increased risks of complications during pregnancy, such as pregnancy-induced hypertension and multiple gestation complications. Such advancements underscore the significance of precise diagnosis, personalized treatment approaches, and interdisciplinary collaboration in managing PCOS effectively. Conclusions: This review undertakes a comprehensive scrutiny of contemporary PCOS studies, illuminating its clinical manifestations, underlying pathophysiological mechanisms, and evolving treatment modalities. Advocating for a patient-centric, evidence-driven approach is imperative in mitigating the adversities associated with PCOS and fostering holistic well-being.Keywords
Funding Information
- Outstanding Talent Research Funding of Xuzhou Medical University (RC20552029)
This publication has 123 references indexed in Scilit:
- Cardiometabolic effects of SGLT2 inhibitors on polycystic ovary syndromeDiabetes/Metabolism Research and Reviews, 2023
- A triple‐blind, randomized controlled trial, comparing combined letrozole and clomiphene versus only letrozole for ovulation induction in women with polycystic ovarian syndromeInternational Journal of Gynecology & Obstetrics, 2022
- Comprehensive evaluation of disparities in cardiometabolic and reproductive risk between Hispanic and White women with polycystic ovary syndrome in the United States: a systematic review and meta-analysisAmerican Journal of Obstetrics and Gynecology, 2022
- The role of miRNAs in polycystic ovary syndrome with insulin resistanceJournal of Assisted Reproduction and Genetics, 2021
- Pathophysiological roles of chronic low‐grade inflammation mediators in polycystic ovary syndromeJournal of Cellular Physiology, 2020
- A comprehensive review of clinical studies with herbal medicine on polycystic ovary syndrome (PCOS)DARU Journal of Pharmaceutical Sciences, 2019
- Racial and ethnic differences in the prevalence of metabolic syndrome and its components of metabolic syndrome in women with polycystic ovary syndrome: a regional cross-sectional studyAmerican Journal of Obstetrics and Gynecology, 2017
- Long and irregular menstrual cycles, polycystic ovary syndrome, and ovarian cancer risk in a population‐based case‐control studyInternational Journal of Cancer, 2016
- Hyperinsulinism and polycystic ovary syndrome (PCOS): role of insulin clearanceJournal of Endocrinological Investigation, 2015
- Effects of Thiazolidinediones on Polycystic Ovary Syndrome: a Meta-analysis of Randomized Placebo-Controlled TrialsAdvances in Therapy, 2012